NO305439B1 - Pyrido(1,2,3-de)kinoksalinderivater og legemidler inneholdende disse - Google Patents

Pyrido(1,2,3-de)kinoksalinderivater og legemidler inneholdende disse

Info

Publication number
NO305439B1
NO305439B1 NO954317A NO954317A NO305439B1 NO 305439 B1 NO305439 B1 NO 305439B1 NO 954317 A NO954317 A NO 954317A NO 954317 A NO954317 A NO 954317A NO 305439 B1 NO305439 B1 NO 305439B1
Authority
NO
Norway
Prior art keywords
pct
quinoxaline derivatives
pyrido
sec
halogen
Prior art date
Application number
NO954317A
Other languages
English (en)
Norwegian (no)
Other versions
NO954317L (no
NO954317D0 (no
Inventor
Ger Martin Kr
Werner Seelen
Lechoslaw Turski
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO954317D0 publication Critical patent/NO954317D0/no
Publication of NO954317L publication Critical patent/NO954317L/no
Publication of NO305439B1 publication Critical patent/NO305439B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO954317A 1993-04-28 1995-10-27 Pyrido(1,2,3-de)kinoksalinderivater og legemidler inneholdende disse NO305439B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4314593A DE4314593A1 (de) 1993-04-28 1993-04-28 Pyrido(1,2,3-de)chinoxalinderivate, Verfahren zu deren Herstellung und ihre Verwendung von Arzneimitteln
PCT/DE1994/000494 WO1994025472A1 (de) 1993-04-28 1994-04-28 Pyrido[1,2,3-de]chinoxalinderivate, verfahren zu deren herstellung und ihre verwendung in arzneimitteln

Publications (3)

Publication Number Publication Date
NO954317D0 NO954317D0 (no) 1995-10-27
NO954317L NO954317L (no) 1995-12-28
NO305439B1 true NO305439B1 (no) 1999-05-31

Family

ID=6487060

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954317A NO305439B1 (no) 1993-04-28 1995-10-27 Pyrido(1,2,3-de)kinoksalinderivater og legemidler inneholdende disse

Country Status (22)

Country Link
US (1) US5750526A (xx)
EP (1) EP0696291B1 (xx)
JP (1) JPH09500359A (xx)
KR (1) KR960701885A (xx)
CN (1) CN1043576C (xx)
AT (1) ATE169925T1 (xx)
AU (1) AU686160B2 (xx)
CA (1) CA2161427A1 (xx)
CZ (1) CZ277795A3 (xx)
DE (2) DE4314593A1 (xx)
DK (1) DK0696291T3 (xx)
ES (1) ES2122274T3 (xx)
FI (1) FI955141A0 (xx)
HU (1) HUT74173A (xx)
IL (1) IL109396A (xx)
NO (1) NO305439B1 (xx)
NZ (1) NZ265600A (xx)
PL (1) PL174418B1 (xx)
RU (1) RU2140924C1 (xx)
SK (1) SK131995A3 (xx)
WO (1) WO1994025472A1 (xx)
ZA (1) ZA942970B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0903144A4 (en) * 1996-04-17 2001-10-31 Sumitomo Pharma MEDICINE FOR RETINAL NEUROPATHY
US6063774A (en) * 1996-12-16 2000-05-16 Warner-Lambert Company Tricyclic quinoxaline derivatives as neuroprotective agents
CN113620890B (zh) * 2020-05-07 2024-06-28 普济生物科技(台州)有限公司 苯并喹喔啉酮化合物及其合成方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2955358B2 (ja) * 1989-06-09 1999-10-04 ファルマシア・アンド・アップジョン・カンパニー 中枢神経系活性を有する複素環系アミン
US5273975A (en) * 1989-06-09 1993-12-28 The Upjohn Company Heterocyclic amines having central nervous system activity
JPH05117276A (ja) * 1991-10-23 1993-05-14 Sumitomo Pharmaceut Co Ltd 新規な3環性キノキサリンジオン誘導体

Also Published As

Publication number Publication date
DE59406739D1 (de) 1998-09-24
ATE169925T1 (de) 1998-09-15
JPH09500359A (ja) 1997-01-14
HUT74173A (en) 1996-11-28
HU9502810D0 (en) 1995-11-28
PL311295A1 (en) 1996-02-05
ES2122274T3 (es) 1998-12-16
DK0696291T3 (da) 1999-05-25
EP0696291A1 (de) 1996-02-14
WO1994025472A1 (de) 1994-11-10
CN1043576C (zh) 1999-06-09
IL109396A (en) 1997-11-20
DE4314593A1 (de) 1994-11-03
AU686160B2 (en) 1998-02-05
KR960701885A (ko) 1996-03-28
PL174418B1 (pl) 1998-07-31
NZ265600A (en) 1996-09-25
AU6675694A (en) 1994-11-21
NO954317L (no) 1995-12-28
RU2140924C1 (ru) 1999-11-10
SK131995A3 (en) 1996-07-03
FI955141A (fi) 1995-10-27
NO954317D0 (no) 1995-10-27
FI955141A0 (fi) 1995-10-27
IL109396A0 (en) 1994-07-31
CA2161427A1 (en) 1994-11-10
CN1121720A (zh) 1996-05-01
US5750526A (en) 1998-05-12
CZ277795A3 (en) 1996-02-14
EP0696291B1 (de) 1998-08-19
ZA942970B (en) 1995-01-19

Similar Documents

Publication Publication Date Title
FR2639636B1 (fr) Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant
ATE51231T1 (de) Pyrimidopyrimidinderivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische zubereitungen und ihre verwendung als antiallergische mittel.
HUP0204354A2 (hu) Új heterociklusos vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
PT902684E (pt) Derivados hexa-hidro-pirido(4,3-b)indolo utilizados como farmacos antipsicoticos
NO305439B1 (no) Pyrido(1,2,3-de)kinoksalinderivater og legemidler inneholdende disse
FI970434A0 (fi) Uudet 3-substituoidut 3H-2,3-bentsodiatsepiinijohdannaiset, niiden valmistus ja käyttö lääkkeenä
NO306781B1 (no) Imidazo[1,2-a]kinoksalinforbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene til fremstilling av medikamenter
AU2001261707A1 (en) Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives
DK0772615T3 (da) Imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylsyrederivater, fremstilling af disse forbindelser og lægemidler indeholdende d
ATE212634T1 (de) Metalloproteaseinhibitoren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
IL67400A (en) Octahydro-3,7a-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them
NO305519B1 (no) Benzo[f]kinoksalindionderivater og legemidler inneholdende disse
ES2122521T3 (es) Derivados de 2'-desoxi-5-fluorouridina y sus sales farmaceuticamente aceptables, procedimiento para su preparacion y agentes antitumorales.
ATE254608T1 (de) Substituierte 2,3-benzodiazepinderivate, verfahren und zwischenprodukte zu ihrer herstellung und diese enthaltende pharmazeutische präparate sowie ihre verwendung
TH35763A (th) ควิโนลีนและสารประกอบควินาโชลีนที่ใช้ประโยชน์ในการรักษา